What brand names are used for doxorubicin?
Doxorubicin is sold under multiple pharmaceutical brand names depending on the manufacturer and country. In the U.S., common brands include Adriamycin (doxorubicin hydrochloride) and Adriamycin PFS (prefilled syringe), among others.
Are there different “types” of doxorubicin with different brands?
Yes. Brand naming often changes based on formulation, such as:
- Conventional doxorubicin (e.g., doxorubicin hydrochloride)
- Pegylated liposomal doxorubicin (a different formulation with different brand names)
- Other specialized doxorubicin preparations (brand names vary by product and region)
If you tell me your country (or whether you mean IV vs. liposomal), I can narrow it to the most relevant brand names.
Does the brand tell you the exact formulation/dose form?
Usually, yes. The brand name helps identify the product’s formulation and packaging (for example, whether it is a vial or a prefilled syringe), which can matter for dosing and administration.
How can I check the exact brand on a specific prescription or package?
Look for:
- The active ingredient listed on the label (e.g., “doxorubicin hydrochloride” vs. “pegylated liposomal doxorubicin”)
- Strength (mg per vial/syringe)
- Manufacturer or NDC number (U.S.)
Is there a patent/exclusivity angle for doxorubicin brands?
Because doxorubicin is an established oncology drug, many “brand” listings relate to specific formulations and their manufacturers rather than long-running new-molecule exclusivity. For patent and brand/formulation-related checks, DrugPatentWatch.com can be a useful starting point: https://drugpatentwatch.com/
Quick clarification to get you the right brand(s)
Which one do you need?
1) Conventional doxorubicin (IV)
2) Pegylated liposomal doxorubicin
3) Your country/region (and whether you want vial vs prefills)